Suscribirse

PERCUTANEOUS NEEDLE BIOPSY OF THE PLEURA - 06/09/11

Doi : 10.1016/S0033-8389(05)70164-0 
Nicholas J. Screaton, BM BChir, MRCP, FRCR *, Christopher D.R. Flower, MB BChir, FRCP(C), FRCR *

Resumen

Pleural disease of inflammatory, infectious, or malignant origin frequently results in pleural thickening often accompanied by pleural fluid. The most frequent clinical manifestation is chest pain, which usually is intermittent and pleuritic in inflammatory or infective disease, and constant when there is malignant involvement. Dyspnea may be related to underlying lung disease, lung restriction caused by pleural encasement, or an associated pleural effusion.

The chest radiograph is the usual first-line investigation when pleural disease is suspected. The typical changes are pleural thickening, which may be localized or diffuse, or a pleural effusion. Cross-sectional imaging techniques, particularly ultrasound (US) and CT, may be used to detect both effusions31 and thickened pleura, and to characterize further the nature of the changes.3, 12, 21, 41, 51 Cytologic analysis of pleural fluid is a sensitive but nonspecific technique in detecting malignant disease; therefore pleural biopsy often is required to establish a diagnosis. When pleural histology is analyzed in combination with cytology from thoracentesis, the diagnostic yield is significantly increased and allows a precise diagnosis to be made in the majority of patients.14, 19, 40, 43, 49 With histologic samples it is not only possible to differentiate accurately between benign inflammatory disease and malignancy but it is also possible to subclassify malignant cell types. This is important in the management of chemosensitive malignancies, including lymphoma, metastatic ovarian, and small cell lung carcinoma. The importance of an accurate diagnosis in mesothelioma relates to claims for compensation.

Cope10 and Abrams1 pleural biopsy needles were developed in the 1950s as a means of obtaining untargeted or closed biopsies from the surface of the parietal pleura. The diagnostic yield of such unguided pleural biopsy has remained low,48 however, and the procedure is restricted to patients with pleural effusions. Image guidance using US,8, 35, 37 CT,16, 17, 35, 46 or fluoroscopy4 enables targeted biopsy of abnormal pleura even when it is focal or otherwise relatively inaccessible or when pleural fluid is minimal or absent.46 This has led to a substantial increase in the yield of pleural biopsy. The introduction of automated biopsy needles, which produce excellent cores with minimal crush artifact, and the use of immunohistochemical techniques15, 26, 38 have further increased the accuracy of pleural biopsy.

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to N. J. Screaton, BM BChir, MRCP, FRCR, Department of Radiology, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, United Kingdom


© 2000  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 38 - N° 2

P. 293-301 - mars 2000 Regresar al número
Artículo precedente Artículo precedente
  • TRANSTHORACIC HILAR AND MEDIASTINAL BIOPSY
  • Zenon Protopapas, Jack L. Westcott
| Artículo siguiente Artículo siguiente
  • CT FLUOROSCOPY FOR THORACIC INTERVENTIONAL PROCEDURES
  • Charles S. White, Cristopher A. Meyer, Philip A. Templeton

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.